Navigation Links
Peakdale Molecular Launches AssayReady4U(TM) in Collaboration With ChemPrintCo LLC
Date:8/27/2008

CHAPEL-EN-LE-FRITH, England and MILPITAS, California, August 27 /PRNewswire/ -- Peakdale Molecular Ltd (CHAPEL-EN-LE-FRITH, UK) a leading provider in specialist chemistry services to the pharmaceutical and biotechnology industry, and ChemPrintCo LLC (MILPITAS, CA, USA), a unique and cost-effective provider of products and systems for the biotechnology industry, today announce the launch of AssayReady4U(TM).

AssayReady4U(TM) is an online based storefront which allows drug discovery researchers the ability to search, design and select compounds from a live physical collection of screening compounds. Then, using additional options, build their final assay by selecting the exact amount and concentration required to perform their own unique experiments.

The final customer-selected compounds are cleanly and accurately dispensed into SBS standard well plates of the customer's choosing using ChemPrintCo's sophisticated and proprietary hydro-acoustic technologies. Each AssayReady4U plate is sealed in an argon environment and then vacuum-sealed in a moisture barrier bag and placed inside a temperature-controlled pack for shipment. All orders are shipped from stock within 24 hours of completion using a commercial carrier. Upon receipt, the customer adds an appropriate amount of solvent to reach the desired test concentration.

Peakdale's collection is fundamentally rich in novel, GPCR-targeted compounds. All compounds in the collection are selected for their applicability to GPCR research. Well-recognized ligand features are combined with proprietary scaffolds and monomers to produce a set of screening compounds for GPCR hit discovery.

Glenn Killingworth, Director of Business Development at Peakdale said: "I am excited that we have built this collaboration in order to reach the smaller drug-research groups who don't want to build assets to store, handle and plate compounds, but just want to receive ready-to-screen assays from a high quality collection, in exactly the format that they need to perform their drug discovery work."

Peakdale's Director of Technology Paul Doyle said: "This represents an exciting new technology that allows a much broader base of researchers to access the world of diverse compounds in a cost effective manner."

Adding to this, ChemPrintCo's Vice President of Sales Ron Jones said: "The AssayReady4U(TM) products will be offered via an innovative web-based one-stop shopping storefront. The researchers will effortlessly select compounds, assay test concentration, plate format, plate manufacturer and controls with a few clicks of a mouse thus optimizing their valuable time for research."

About Peakdale Molecular

Peakdale Molecular was founded in 1992. Today the company's customers include the majority of the major global pharmaceutical businesses and a rapidly growing base of biotechnology companies worldwide. Peakdale's teams of chemists combine experience in pharmaceutical R&D, medicinal chemistry, parallel synthesis, process development and fine chemicals to deliver unique chemistry solutions to a range of drug discovery challenges. Peakdale has growing capabilities in computational chemistry, analytical chemistry and ADME screening.

The application of less commonly used chemistry, including high temperature/pressure reactions, proprietary heterocyclic chemistry and nucleoside synthesis, enables Peakdale's chemists to generate unique compounds for drug discovery. Peakdale operates in several distinct markets providing novel screening compounds, targeted screening libraries, catalogue intermediates, custom synthesis and contract research. Further information about the company can be obtained at http://www.peakdale.com

About ChemPrintCo LLC

ChemPrintCo is a privately held company located in the heart of Silicon Valley and the Bay Area's deep biotech and pharmaceutical community. The management team has been together for over 15 years developing unique and cost-effective products and systems for the biotech and high-technology industries. Their mission is to address the needs of the individual scientific researcher with ready-to-use assays in a single-use well plate format. We accomplish this by giving each researcher the ability to select compounds from leading suppliers in the exact amount and concentration required to perform their own unique experiments.

For more information please contact

Peakdale Molecular Ltd ChemPrintCo LLC

Glenn Killingworth Roger Williams

Director of Business Development President

Peakdale Molecular Ltd ChemPrintCo. LLC

Peakdale Science Park 1804 McCarthy Boulevard

Sheffield Road Milpitas

Chapel-en-le-Frith California

High Peak 95035

UK USA

Tel +44(0)1298-816700 Tel +1-408-273-2300

Fax +44(0)1298-816701

http://www.peakdale.com/AssayReady4U.htm

http://chemprintco.googlepages.com/home


'/>"/>
SOURCE Peakdale Molecular Ltd and ChemPrintCo LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Peakdale Molecular Announces GBP 1 Million Funding to Support Expansion and Growth
2. PAREXEL Data Indicate U.S. Marketing Applications for New Molecular Entities Bounce Back
3. VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent
4. Molecular sleuths track evolution through the ribosome
5. Amsterdam Molecular Therapeutics Reports Half Year Results 2008
6. Molecular Biometrics Announces Results of Parkinsons Disease Research and Receipt of Grant From Michael J. Fox Foundation to Advance Diagnostic Technology
7. Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics
8. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
9. Xceed Molecular to Launch New Inflammation Xpress Chip(TM)for the Ziplex(R) Automated Gene-Expression Analysis System at Clinical Lab Expo 2008, Booth 2155
10. Molecular hula hoop
11. Noted Molecular Epidemiologist Joins Cepheid to Head Healthcare Associated Infection Consortium Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology:
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
(Date:5/12/2016)... 12, 2016 WearablesResearch.com , a brand ... overview results from the Q1 wave of its quarterly ... was consumers, receptivity to a program where they would ... health insurance company. "We were surprised to ... Michael LaColla , CEO of Troubadour Research, "primarily ...
Breaking Biology News(10 mins):